Detalles de la búsqueda
1.
A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.
Cancer Immunol Immunother
; 73(2): 33, 2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280081
2.
Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy.
Ann Hematol
; 103(3): 969-980, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38214708
3.
Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti-CD19-chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B-cell lymphoma and high tumor burden.
Hematol Oncol
; 41(2): 275-284, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35195933
4.
Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL.
Ann Hematol
; 102(7): 1789-1799, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171599
5.
Humanized anti-CD19 chimeric antigen receptor-T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection.
Hematol Oncol
; 39(1): 75-86, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32949412
6.
Defining early hematopoietic-fated primitive streak specification of human pluripotent stem cells by the orchestrated balance of Wnt, activin, and BMP signaling.
J Cell Physiol
; 234(9): 16136-16147, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30740687
7.
Upregulation of CD72 expression on CD19+ CD27+ memory B cells by CD40L in primary immune thrombocytopenia.
Br J Haematol
; 178(2): 308-318, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28419421
8.
Stromal cell-derived factor-1 rs2297630 polymorphism associated with platelet production and treatment response in Chinese patients with chronic immune thrombocytopenia.
Platelets
; 27(4): 338-43, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26587874
9.
Sequential cellular niches control the generation of enucleated erythrocytes from human pluripotent stem cells.
Haematologica
; 105(2): e48-e51, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31197070
10.
Knockdown SENP1 Suppressed the Angiogenic Potential of Mesenchymal Stem Cells by Impacting CXCR4-Regulated MRTF-A SUMOylation and CCN1 Expression.
Biomedicines
; 11(3)2023 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979893
11.
Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant.
Cell Transplant
; 32: 9636897231158155, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36879459
12.
The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.
BMC Med Genomics
; 16(1): 296, 2023 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980495
13.
Evaluation of the safety and efficacy of humanized anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma based on the comprehensive geriatric assessment system.
Leuk Lymphoma
; 63(2): 353-361, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587859
14.
A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients.
Cell Transplant
; 31: 9636897221076050, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35168385
15.
Risk factors for inhibitors in hemophilia A based on RNA-seq and DNA methylation.
Res Pract Thromb Haemost
; 6(6): e12794, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36090157
16.
Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk.
Front Oncol
; 11: 706087, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34395279
17.
Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy.
Onco Targets Ther
; 14: 4023-4037, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34239307
18.
Vitronectin-activated αvß3 and αvß5 integrin signalling specifies haematopoietic fate in human pluripotent stem cells.
Cell Prolif
; 54(4): e13012, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33656760
19.
Synergistic effect of programmed death-1 inhibitor and programmed death-1 ligand-1 inhibitor combined with chemotherapeutic drugs on DLBCL cell lines in vitro and in vivo.
Am J Cancer Res
; 10(9): 2800-2812, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33042618
20.
Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant.
Front Oncol
; 10: 573822, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33117709